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Purpose: The vascular smooth muscle cell plays a pivotal role in the development of 
atherosclerosis. The objectives of this study were to characterize smooth muscle cells from 
the human atherosclerotic tibial artery to determine their phenotypic properties and to 
examine the contractile reactions of these cells to physiologic and pharmacologic stimuli. 
Methods: After below-knee amputations were performed, vascular smooth muscle cells 
were harvested and cultivated from tibioperoneal source. Characterization was done with 
transmission electron microscopy and immtmocytochemistry. The contractile properties 
were determined by observing the response to various stimuli. In addition, segments of 
vessels harvested were submitted to electron microscopy studies for comparison with the 
cultured cells. 
Results: Immunofluorescent labeling was positive for cz-smooth muscle actin. Electron 
microscopy revealed the presence of a thickened basal aminae and large intracellular lipid 
vacuoles. The earlier passages revealed cells with a large number of microfilaments 
characteristic of a contractile cell. As later passages were examined, there was a notable 
change in character with an increasing amotmt of rough endoplasmic reticulum and Golgi 
complexes. The increased thickness of the basal amina in the cultured cells resembled that 
fotmd in vessel segments studied by electron microscopy. A rapid contraction response was 
seen when the cells were incubated with angiotensin II, bradykinin, or endothelin. No 
response was seen with the addition of isoproterenol, nitroglycerin, or nitroprusside, 
known smooth-muscle r laxants. 
Conclusion: This model demonstrates the apparent inability of these smooth muscle cells 
from atherosclerotic ibial arteries to relax to pharmacologic and physiologic stimuli. In 
addition, as seen by transmission electron microscopy, these cells maintain their athero- 
sderotic phenotype after multiple passages. (J Vase Surg 1996;24:883-91.) 
The vascular smooth muscle cell (VSMC) plays an 
integral role in the atherosclerotic process. VSMCs 
migrate from the media to the intima, where they 
continue to proliferate and secrete xtracellular matrix 
components that contribute to the atherosclerotic 
lesion. ~ 
It has been demonstrated that the VSMC in vitro 
undergoes phenotypic hanges including a loss of 
contractility and a change in biosynthetic apabili- 
ties. 2'3 The tibioperoneal rterial bed is a specific site 
involved in atherosclerosis in a large group of  patients 
with lower extremity ischemia. This condition gener- 
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ally begins in early adult life with slow progression to 
increasing levels of stenosis or eventual occlusion. 4 
Atherosclerosis has been extensively studied, and 
much has been learned regarding its pathophysiologic 
characteristics. However, little has been described 
concerning the peripheral atherosclerotic process es- 
pecially in the tibioperoneal distribution and whether 
the phenotypic expression of the VSMCs in the 
tibioperoneal rea are affected. The objectives of this 
study included (1) to determine the phenotypic 
expression of the infragenicular VSMCs from athero- 
sclerotic tibial vessels and (2) to observe the contrac- 
tile properties of  these cells in response to physiologic 
and pharmacologic stimuli. 
MATERIAL  AND METHODS 
Cell culture. Primary cell culture of the infrage- 
nicular VSMC was obtained with the enzymatic 
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dispersion technique as used by Parkes et al. 5 Imme- 
diately after below-knee amputations were com- 
pleted, approximately 10 cm segments of the tibial or 
peroneal arteries were isolated from the specimen 
side. All five donors had terminal ischemia with 
contraindication to revascularization a d were dia- 
betic men with ages ranging from 55 to 70 years. The 
segments were then immediately placed in cold 
(-4 ° C) C-100 culture media (Gibco, Grand Island, 
N.Y.) supplemented with 1% antibiotic-antimycotic 
(10,000 U/ml  penicillin G sodium, 10,000 ~tg/ml 
streptomycin sulfate, and 25 ~tg/ml amphotericin B; 
Gibco). 
The adventitia nd grossly calcified intimal plaque 
were teased and separated from the media. The 
remaining specimen (mainly media) was then minced 
and placed into a 50 ml centrifuge tube with C-199 
media, 1% antibiotic-antimycotic, 10% fetal bovine 
serum (Gibco), 0.8% collagenase (Worthington Bio- 
chemical, Freehold, N.J.), and 0.05% elastase 
(Worthington Biochemical). The media was then 
incubated in a shaking 37 ° C water bath for approxi- 
mately 3 hours, at which time the suspension ap- 
peared cloudy. The cellular suspension was then 
filtered with a 200 ~tm nylon mesh and centrifuged at 
80g for 2 minutes. The supernatant was discarded, 
and the procedure was repeated with phosphate- 
buffered solution (pH 7.4, Gibco) to wash the cells of 
further debris. The cells were then resuspended in
C-199 media containing 10% fetal bovine serum 
and 1% antibiotic-antimycotic and were seeded into 
25 cm 2 cell culture flasks (Fischer, Springfield, N. J.). 
All experiments were done with cells from passages 
3 through 7. 
Immunocytochemistry. Identification and char- 
acterization of the cultured cells were done with 
immunofluorescence staining. The following primary 
antibodies were used: (1) 1 : 200 monoclonal anti-a- 
smooth-muscle actin (A-2547, Sigma, St. Louis, 
Mo.), (2) 1:200 monoclonal antimyosin (M-7786, 
Sigma), (3) 1:40 monoclonal antivimentin (V-6630, 
Sigma), (4) 1 : 20 rabbit antidesmin (D-8281, Sigma), 
(5) 1:150 monoclonal antivitronectin (V-7881, 
Sigma), (6) 1:150 monoclonal anticellular fibronec- 
tin (F-6140, Sigma), and (7) 1:200 monoclonal 
antichondroitin sulfate (C-8035, Sigma). Counter- 
staining was done with the following fluorescein- or 
rhodamine-conjugated secondary antibodies: (1) 
fluorescein isothiocyanate conjugate goat antimouse 
immunoglobulin G (F-2012, Sigma) and (2) fluores- 
ccin isothiocyanate conjugate donkey anti-rabbit 
immunoglobulin G (DAKO, A/S Productionsvej, 
Denmark). 
Passage 3cells were seeded into single-well culture 
chamber slides (Fischer). The cells were prepared and 
stained on the third day of culture. Cells were washed 
several times with phosphate-buffered solution (with 
Ca 2+ and Mg 2+, hereafter PBS++) and fixed in 100% 
methanol for 10 minutes at -20 ° C. The cells were 
again washed several times with PBS (without Ca 2+ or 
Mg 2+, hereafter PBS-), and each chamber slide was 
then administered one of the primary antibodies in 
PBS- with 0.2% albumin and allowed to incubate at 
37 ° C for 45 minutes in a humidified 5% CO 2 
incubator. After three additional Washings with PBS- 
the secondary antibodies (1:100 dilution) were ad- 
ministered and incubated in the same environment 
for a final 45 minutes. On completion of the second- 
ary antibody labeling the cells were washed with 
PBS-. Slides were mounted with SlowFade antifade 
reagent in PBS (Molecular Probes, Eugene, Ore.) and 
studied under an Epifluorescence Microscope (Ni- 
kon, Garden City, N. J.). To detect any autofluores- 
cence separate slides were prepared and viewed in the 
absence of any primary or secondary antibody. 
Electron microscopy. At the time of vessel har- 
vest 5 mm segments were obtained, minced, and then 
washed with PBS++ three times. They were initially 
fixed with phosphate-buffered 2% paraformalde- 
hyde-l% glutaraldehyde for 15 minutes. At room 
temperature fresh fixative was added for an additional 
60 minutes. After fixation was performed the vessel 
segments were washed three times in bufferd sucrose 
(0.1 mol/L phosphate buffer, 5% sucrose solution, 
pH 7.4) for 5 minutes each and postfixed at 4 ° C for 
an additional 60 minutes in phosphate-buffered 2% 
osmium tetroxide. With a graded series of ethanol 
(70%, 70% to 100%, and 100%) followed by propylene 
oxide (1:1 with 100% ethanol, then 100% propylene 
oxide) the tissue was dehydrated. 
Embedding was carried out in Durcurpan ABCD 
(Sigma). Semithick sections were cut and stained with 
0.5% Toluidine blue (Gibco) for initial viewing by 
light microscopy. Ultrathin longitudinal and cross 
sections were mounted on 300 mesh copper grids 
(6 grids/area). These specimens were enhanced with 
uranyl acetate and lead citrate for 1 to 2 minutes. 
Photographs were taken with electron microscopy 
film (Kodak, Estar, Thick Base, 4489, Rochester, 
N. Y.). In a similar fashion en face and longitudinal 
light gold sections (1000'A) from randomly selected 
areas were fixed and evaluated. 
Cell contractility. Contractility studies with sili- 
cone rubber substrata were used. A small amount of 
the silicone rubber was applied to 20 mm 2 sterile glass 
coverslips. These were then centrifuged at 80g for i0 
minutes to obtain a thin even coating of silicone 
rubber across the coverslip glass. The coverslips were 
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Hg. 1. Compositephotomicrographdemonstratingimmunofluorescentimagesofmonoclonal 
anti-c~-smooth muscle actin an body (passage 3). Extent of labeling to leading edge of cell is 
evident in A (open arrows). Most filaments are running along long axis of calls in B (solid arrow). 
Note also no nuclear staining. Magnification x200. 
flamed for 1 to 3 seconds to polymerize the outermost 
layer (skin) while maintaining the liquid silicone 
beneath the skin. Coverslips were placed into 35 mm 2 
petri dishes and sterilized by placement under ultra- 
violet irradiation for 24 hours. 
When cells are seeded onto the silicone rubber 
substrata, their tonic ontraction and contraction and 
relaxation to stimuli can be evaluated by noting the 
elastic distortion and wrinkling of the substratum. 6,7 
The distortion appears to be specific to cellular 
contractile capability and not cell motility. 8
Cells from passages 3 through 5 were seeded on 
the sterilized silicone coated coverslips at low density 
(4 x 10-3/cm2). To allow for adequate matrix devel- 
opment and baseline tonic contraction to develop, the 
cells were incubated for 48 to 72 hours at constant 
conditions of 5% C02, 37 ° C, and humidification. 
Contraction and relaxation responses were ob- 
served by stimulating the cells with the following drug 
preparations: (1) angiotensin I]E, 3 x 10 -7 tool /L,  (2) 
bradyldnin, 3 x 10 -7 tool/L,  (3) endothelin I, 10 -7 
mol /L ,  (4) isoproterenol 10 -3 mol /L  to 10 -7 tool /L,  
(5) nitroglycerin, 6.7 x 104 mol /L ,  (6) sodium ni- 
troprusside, 6.7 x 104 mol /L ,  (7) papaverine, 10 -7 
tool /L,  and (8) serotonin, 10 -7 mol /L .  The prepa- 
rations were placed in serum-free C-199 media and 
warmed to 37 ° C in a 5% CO 2 humidified incubator. 
Cells were observed for at least 30 minutes for a 
JOURNAL OF VASCULAR SURGERY 
886 Jones et aL November 1996 
Fig. 2. Composite lectron micrograph of tibial smooth 
muscle cells in culture showing three phenotypes seen: A, 
contractile state (passage 3); B, intermediate state (passage 
5); C, synthetic state (passage 7). In A, note extent of 
microfilaments (MF) throughout cytoplasm and highly 
irregular nuclear shape (N). Solid arrowheads denote dense 
plaques periodicity along MF. In B there is increase in 
number of ribosomes and polyribosomes (R). In later 
passage (C) there is disappearance ofMF. LYS, Secondary 
lysosomes; LP, neural lipids. Magnification (A) x4,150, (B) 
x3,500, (C) x5,100. 
response. Contractions were interpreted as an in- 
crease in the length or the number ofwrinldes in the 
silicone rubber substratum. Relaxation responses 
were interpreted as just the opposite, adecrease inthe 
length or number ofwrinldes. The appropriate ime of 
onset, peal~ effect, and reversal of initial response was 
recorded. To determine relaxation potential from a 
contracted state, contracting agents were initially 
given in the doses described previously. 
RESULTS 
Immunocytochemistry of cytoskeletal and ma- 
trix proteins. Differentiated smooth muscle cells 
demonstrated characteristic ytoskeletal proteins. 
With antibodies to c~-smooth muscle actin and 
smooth muscle myosin, specific identification ofthese 
cells was ascertained. Binding patterns of m-smooth 
muscle actin were consistent throughout each speci- 
men and each cell passage studied. A strong binding 
pattern was evident in all cells showing the character- 
istic actin cable network of long, straight, noninter- 
rupted filaments that were oriented primarily along 
the long axis of the smooth muscle cells extending 
throughout the cytoplasm and to the leading edges. 
There was no nuclear staining or cytoplasmic staining 
between actin microfibtils. Nearly all the cells dem- 
onstrated m-smooth muscle actin (Fig. 1). The char- 
acteristic pattern of myosin was not revealed in all cells 
with smooth muscle myosin immunofluorescence 
labeling. Fibronectin was seen throughout and 
around the SMCs with its characteristic fibrillar pat- 
tern, whereas chondroitin sulfate was diffusely seen 
and not confined to the cells. Slides prepared in the 
absence of any primary or secondary antibody dem- 
onstrated no autofluorescence. 
Electron microscopy. These smooth muscle cells 
showed either the Contractile, intermediate, or syn- 
thetic phenotype depending on the passage studied 
(Fig. 2). The contractile smooth muscle cells were 
characterized by extensive microfilaments running 
mostly parallel to the long axis of the cell. Electron- 
dense bodies were irregularly spaced along the mi- 
crofilaments, which often terminated at the dense 
subplasmal plaque. Rough endoplasmic rcticulum 
and Golgi complexes were less conspicuous cytoplas- 
mic components and were confined to the perinuclear 
space. Both gaplike junctions and junctional com- 
plexes were observed. The extracellular matrix 
showed numerous microfibrils and highly organized 
collagen bundles with striations. The contractile phe- 
notype predominated in early-passage c lls. 
The synthetic phenotype cells are characterized as
cells that engage in the synthesis of extracellular 
matrix, cell division, or both. This phenotype was 
observed in our late-passage cultures. Their cyto- 
plasm was found to be filled with well-developed 
rough endoplasmic r ticulum that are often dilated 
with amorphous materials. The cell had extensive free 
ribosomes and polyribosomes. The Golgi apparati 
were prominent with few sparse microfilaments 
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Fig. 3. Composite lectron micrograph demonstrating portions of two synthetic fibial VSMCs 
(passage 7). A, Prominent Golgi apparatus (GA) and coated pits (solid arrowheads) can be seen. 
Extent of micropinocytotic vesicles can be seen in B, occurring either singularly (,small solid 
arrows) or in clusters (open arrows). MV, Multivesicular bodies; CV, coated vesicles. Magnifica- 
tion, (A) x32,000, (B) x20,000. 
mostly located at the cell periphery. Micropinocytofic 
vesicles were seen at the plasmalemma aseither single 
vesicles or more often in clusters. Coated pits 
(caveale) were observed (Fig. 3). Multiple cellular 
mitoses were also evident. 
Early in culture the smooth muscle cells showed a 
thin partial (incomplete) basal lamina that progres- 
sively increased in both thickness and extent (Fig. 4). 
A very thickened basal lamina was seen with pro- 
longed culture periods. The thickened basal lamina 
was similar to that observed in atherosclerotic tibial 
vessels (Fig. 5). Nuclei of the contractile cells were 
often globulated, whereas the nuclei of the synthetic 
cells were mostly ovoid and euchromatic. The cells 
showed several secondary l sosomes, with many con- 
taining myelin figures. Early in culture, complex lipid 
droplets were noticed; these became more neutral in 
late passages. 
Cell contractility. Contractility responses were 
measured after 48 to 72 hours of incubation on the 
silicone matrix. Before any drug preparations were 
added, it was believed that the cells should manifest a
baseline tonic contraction to establish that they were 
indeed viable and capable of contracting. With the 
addition ofangiotensin II, endothelin I, or bradykinin 
all cells responded rapidly by contracting, as noted by 
the rapid evolution of wrinkles on our substratum 
(Fig. 6). Angiotensin II was subsequently used as our 
drug of choice when further contraction responses 
were desired. Table I illustrates the contraction or 
relaxation responses to all added substances. 
No response was elicited 'with the addition of 
known smooth-muscle r laxants isoproterenol, so- 
dium nitroprusside, ornitroglycerin. The drugs were 
allowed to incubate with the cells for a minimum of 30 
minutes. In contrast, the addition of serotonin and 
papaverine (also known to stimulate smooth muscle 
relaxation) revealed varying relaxation results. Sero- 
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Fig. 4. Composite lectron micrograph (passage 3 cells). A shows incomplete basal lamina 
(open arrows). Note close association f basal lamina with subplasmalemmal plaque (solid 
arrowheads) adjacent to where thin actin cortical filaments are ending (small solid arrows). B, 
Later passage (passage 7) shows almost complete basal lamina (open arrows). RER, Rough 
endoplasmic reticulum; DP, dense plaques; M, myelin figure. Magnification, (A) x25,000, (B) 
x16,000. 
tonin produced relaxation in approximately 50% of 
the cells, and the response was usually sluggish and 
occurred after 10 to 15 minutes of incubation. This 
response was seen only after initial contraction was 
elicited by angiotensin I I  and was not seen when 
serotonin was given to a baseline contracted cell. A 
brisk and consistent response was seen only with the 
addition of papaverine at a concentration of 10 -7 
mol /L .  These cells showed relaxation within 15 
minutes. This relaxation was seen from the tonic- 
contracted state and after angiotensin I I  stimulated 
contraction. 
DISCUSSION 
The VSMC plays a pivotal role in the atheroscle- 
rotic process in humans. Multiple studies have re- 
ported the characteristics of human coronary arterial 
VSMCs and nonhuman VSMCs in culture, but infor- 
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Fig. S. Composite electron micrograph showing extensive extracellular basal lamina-like matrix 
deep to multilayered tibial smooth muscle cells in culture (A, open arrows). There is also thickened 
basal laminae (open arrows) associated with smooth muscle cells from atherosclerotic tibial artery 
as indicated in B. MF, Microfilaments; M, mitochondria; GA, Golgi apparatus; RER, rough 
endoplasmic reticulum; N, nucleus; DP, dense plaques, arroms, cluster of micro- 
pinocytotic vesicles. Magnification, (A) x12,500, (B) x8,500. 
marion from peripheral vascular smooth muscle cells 
is limited. 9-13 This study represents an attempt o 
characterize the phenotypic expression and contrac- 
tility properties of vascular smooth muscle cells from 
a human atherosclerotic infragenicular source. We 
have used a method of reliably cultivating vascular 
smooth muscle cells by the enzymatic dispersion 
technique. From this technique we established a
primary cell culture line after harvest of whole vessel 
segments subsequent to lower extremity amputation. 
The VSMC has been described as existing in two 
phenotypes: the contractile state and the synthetic 
state.~,s,9a4 The contractile state is characterized by a 
larger number ofmyofilaments coalescing into dense 
bodies (principally m-smooth muscle actin and myo- 
sin), the paucity of the cytoskeleton i termediate 
protein vimentin, and morphologic characteristics of 
a spindle-shaped cell when seen under light micros- 
copy. 9'~5 This form predominates in the adult patientJ 
On the other hand, the VSMC in the synthetic 
phenotype has less myofilaments including a switch 
from m-smooth muscle actin to ]3-actin, a decrease in 
myosin, an incrcascd number of thc organelles re- 
sponsible for the synthetic processes (rough endoplas- 
mic reticulum and Golgi complexes), and an en- 
hanccd ability to synthesize extracellular matrix pro- 
teins. 1,16,17 Synthetic and subcultured cells produce 
collagen, clastin, and protcoglycansJ 4'18 The syn- 
thetic phenotype smooth muscle cell is commonly 
seen in the neonatal period and in atherosclerosis. 19,20 
Babaev et al. 19 noted the increased presence ofdesmin 
in 7 of 28 specimens with atherosclerosis. They also 
reported the increased presence ofvimentin i  normal 
aortic specimens, which would seemingly be in the 
contractile state. Earlier studies have indicated a 
decrease in desmin in the atherosclerotic synthetic 
state.16,17 
Cultured smooth muscle cells change their phe- 
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Table I. Response of cultured tibial smooth 
muscle cells to various physiologic and 
pharmacologic stimuli 
Concentration 
Agent (mol/L) Response 
Angiotensin II 3 X 10 .7 Rapid contraction 
within 5 min 
Bradyldnin 3 X 10 -7 Rapid contraction 
within 5 min 
Endothelin I I 0-7 Rapid contraction 
within 5 rain 
Isoproterenol 10-3M, 10 -7 No response 
Nitroglycerin 6.7 × 10 -4 No response 
Nitroprusside 6.7 × 10 -4 No response 
Serotonin 10 -7 Sluggish relaxation 
in approximately 
50% of the cells 
within 10 min 
Papaverine 10 -7 Brisk relaxation 
Fig. 6. Composite phase contrast micrograph of tibial 
smooth muscle cells cultured on rubber substratum (pas- 
sage 3). A, Before adding angiotensin II. B, Response after 
adding angiotensin II (3 x 10 -7 mol/L, solid arrowheads). 
C, Cells seen before adding endothelin I. D, Twenty 
minutes after adding e dothelin I (10 .7 mol/L), a marked 
increase in wrinkling and lengthening of preexisting 
wrinkles are sccn (open arrows). E, Cells seen before adding 
bradykinin. F, Contraction response seen after addition of 
bradykinin (3 x 10 -7 mol/L, solid arrows). Magnification 
x200. 
notype rapidly in the in vitro environment to eithcr a 
synthetic phenotype or to a cell with fibroblast-like 
morphologic characteristics. 1,14,21 Sprinlde et al) 4 
showed that fetal rat aortic smooth muscle cells 
undergo phenotype changes as early as 3 days in 
culture. However, explants from their adult rat aorta 
maintained the contractile predominance when left in 
serUm-free media. In fact, synthetic phenotype 
smooth muscle cell proliferation occurrcd in adult 
explants only when supplemented with serum (after 
15 days). Although the exact reason behind this 
change of phenotype has not been determined, the 
effects of fibronectin have been postulated to be 
important. 1,22 It has been shown that fibronectin 
promotes the transition of cells from a contractile to a 
synthetic state. 
In this study these smooth muscle cclls from a 
peripheral atherosclerotic source presented with find- 
ings consistcnt with both the synthetic and contractile 
phenotypic states. Immunofluorescent staining re- 
vealed a large distribution of a-smooth muscle actin 
characteristic of the contractile state and a modestly 
increased amount of staining ofvimentin and chon- 
droitin sulfate in the later passages. The electron 
microscopic findings were more consistent with a 
synthetic phenotype, showing dense perinuclear 
rough endoplasmic reticulum and Golgi bodies, lipid 
inclusions, and a thickcned basal amina. These char- 
acteristics appeared to predominate in the later pas- 
sages. The increased thickness of basal lamina in 
cultured cells was comparable to that found in vessel 
specimcns tudied with electron microscopy. This 
finding may constitute a constant phenotypic feature 
of these cells. 
Contractility properties were identified to phar- 
macologic and physiologic stimuli. The technique of 
cell isolation and growth left us with a nearly pure 
smooth muscle cell culture with the absence of 
endothelial cells. The absence ofendothelium limited 
our use of drugs known to produce endothelium- 
dependent relaxation such as acetylcholine. 23 
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Although these cells brisldy contractcd in response 
to contracting agents such as bradykinin, angiotensin 
II, and endothelin I, they did not respond to known 
smooth muscle relaxants uch as isoproterenol, nitro- 
glycerin, and sodium nitroprusside. However, incu- 
bation with papaverine led to relaxation. The cells 
incubated with papaverine did show viability and 
contractile potential, because they either had a tonic 
baseline contraction or had responded to angiotensin 
II before the addition ofpapaverine. 
we have demonstrated the successful harvest and 
cultivation of vascular smooth muscle cells from an 
atherosclerotic tibial vessel source with the enzymatic 
dispersion technique. These cells displayed the find- 
ings of a synthetic and contractile phenotypes. The 
synthetic phenotype smooth muscle cell included 
dense pcrinuclear rough endoplasmic reficulum, 
Golgi bodies, extensive polyribosomes, a thickened 
basal lamina, and marked immunofluorescent stain- 
ing to the extraccllular matrix component vimentin. 
The use of early passage cells was believed to better 
mimic their in vivo characteristics. The contractile 
phenotype smooth muscle cell included extensive mi- 
crofilament on electron microscopy studies and posi- 
tive immunocytocliemistry labeling for c~-smooth 
muscle actin. Contractile properties with the silicone 
rubber substratum method revealed a lack of response 
to known smooth muscle cell relaxants, indicating an 
impaired contractile function. This impairment in 
contractility of these cells may prove to be an impor- 
tant defect characterizing the atherosclerotic lesion. 
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